trending Market Intelligence /marketintelligence/en/news-insights/trending/4H6ch-Q3IDn0-sS_s22JMg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Report: Justice Department skeptical of Aetna/Humana deal

Part Two IFRS 9 Blog Series: The Need to Upgrade Analytical Tools

2018 US Property Casualty Insurance Market Report

Fintech

Fintech Funding Flows To Insurtech In February

Lemonade Growing Premiums Faster Than Esurance's Homeowners Business Did


Report: Justice Department skeptical of Aetna/Humana deal

Sharesof Humana Inc. dropped sharplyin afternoon trading July 7, amid fresh concerns that its planned with Aetna Inc. could face federal antitrust objections.

The healthinsurer's stock fell 10.70% to $160.73 as of 3:31 p.m. ET. Aetna's shares also slidthroughout the afternoon, down 4.53% to $114.79.

Antitrust-focusedpublication MLex reported the same day that the U.S. Justice Department is skepticalof the potential tie-up, which would join two of the nation's largest publicly tradedhealth insurers. Federal officials are concerned that the deal could hurt competitionwithin the industry, with Bloomberg News reportingthat they will discuss the possibility of Aetna selling some of its assets duringa July 8 meeting.

The meetingcomes soon after Justice Department officials expressedserious concerns about Anthem Inc.'smultibillion-dollar deal to acquire CignaCorp.

Humana'splanned merger with Aetna is undergoing a federal antitrust review and individualreviews in states where the deal could significantly affect their respective healthinsurance markets. The Missouri Insurance Department in May became the first stateagency to object to thedeal, finding that it would violate competitive standards.